Videos

  • Michael Bozik, CEO, Knopp Biosciences, LLC

  • John Brennan, Chief Development Officer, Glycadia Pharmaceuticals

  • Susan Catalano, Chief Science Officer, Cognition Therapeutics, Inc.

  • David Chambers, Senior Counsel, IP Smith & Nephew, Inc.

  • Judd Englert, VP of Clinical Research and Development, Cyteir Therapeutics

  • Mike Hoerres, CEO, Cernostics

  • Jed Johnson, Co-Founder and CTO, Nanofiber Solutions

  • Ross Kayuha, CEO, Nanofiber Solutions

  • Todd Krueger, President, Chief Executive Officer, Aobiome

  • Tim Londergan, CEO, Wavefront Venture Labs

  • Anne Maher, President, Merit1 Management

  • Dennis Hauck, Owner

  • Amany Mansour-Awad, CEO, ChemistryRx

  • Craig Markovitz, Corporate Innovation & Entrepreneurship Specialist, Troutman Pepper

  • Ray Miller, Partner, Troutman Pepper

  • Richard Mimna, Executive Director of R&D, Calgon Carbon

  • Tory Moore, Vice President and CEO, Ariel Precision Medicine

  • Aparna Nemlekar, Assistant Counsel, PPG Industries, Inc.

  • James Nolan, Operations Partner, Velocity Fund Partners

  • John Nottingham, Co-President, Nottingham Spirk

  • Megan O’Gara, Associate, Troutman Pepper

  • Ketal Patel, Partner, F-Prime Capital

  • Pierre Queiroz de Oliveira, Associate, Troutman Pepper

  • Vivek Ramaswamy, Founder and CEO, Roivant Sciences

  • Hank Safferstein, CEO, Generian

  • David Seemungal, Director, Cubase Consulting Limited

  • David Smith, Counsel, Troutman Pepper

  • Nicole Stakleff, Partner, Troutman Pepper

  • Cal Stein, Partner, Troutman Pepper

  • Marcy Tenaglia, SVP, CLO & Secretary, Henkel Corporation

  • Teresa Whalen, CEO, CytoAgents, Inc.

  • Patrick Treado, Founder and CTO, ChemImage Corporation

  • Joe Robinson, Partner, Troutman Pepper

  • Monte Browder, Chief Patent Counsel, Opka Health, Inc.

  • Samuel Reich, Executive Chairman, Biscayne Neurotherapeutics (sold to Supernus Oct 2018)

  • David Abramson, Principal, SDA Ventures, LLC

  • Sarabjit Ashta, Chief Business Officer, Glycadia Pharmaceuticals

  • Michael Bozik, CEO, Knopp Biosciences, LLC

  • David Chambers, Senior Counsel, IP, Smith & Nephew, Inc.

  • Steve Dubin, Principal, SDA Ventures LLC

  • Brian Dunn, Executive Vice President, Strategy & Corporate Development, Matthews International

  • Miranda Hooker, Partner, Troutman Pepper

  • Deborah Kovsky-Apap, Partner, Troutman Pepper

  • Dennis Hauck, Owner, Self

  • Anne Maher, President, Merit1 Management

  • Amany Mansour-Awad, CEO, Chemistry Rx

  • Craig Markovitz, Corporate Innovation & Entrepreneurship Specialist, Troutman Pepper

  • Raymond Miller, Partner, Troutman Pepper

  • James Nolan, Operations Partner, Velocity Fund Partners

  • John Nottingham, Co-President, Nottingham Spirk

  • Ketan Patel, Capital Partner, F-Prime

  • Andrew Powell, Advisor, Autem

  • David Seemungal, Director, Cubase Consulting Limited

  • David Smith, Counsel, Troutman Pepper

  • Mimi Tang, Acting CEO, Prota Therapeutics

  • Marcy Tenaglia, SVP, CLO & Secretary, Henkel Corporation

  • Melvin Washington, Chief Risk Officer, Tristate Capital

  • Joseph Robinson, Partner, Troutman Pepper

  • Tom Dubensky, CEO, Tempest Therapeutics

  • Michael Tung, Investor Relations Strategy, FibroGen, Inc.